Eli Lilly Rallies After Earnings Beat, Higher Sales Outlook, and Pipeline Momentum

Eli Lilly and Company (LLY) is up 6.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied mainly to a strong third-quarter report that beat expectations, a higher full-year revenue outlook, and continued strength in Lilly’s obesity and diabetes franchise. Additional support likely came from positive late-stage data for retatrutide, which added more pipeline momentum heading into the earnings release.

Details:

Lilly reported third-quarter 2026 revenue of $24.4 billion, up 39%, with non-GAAP earnings per share of $7.48.

The company raised its 2026 revenue guidance to $91 billion to $92 billion, a sizable increase from its prior range.

Demand for Mounjaro and Zepbound remained a major driver, with both products posting sales above market expectations.

Lilly also highlighted positive Phase 3 results for retatrutide against Ozempic 2 mg in adults with type 2 diabetes, reinforcing investor enthusiasm around its next wave of obesity and diabetes products.

Sources:

Eli Lilly, Reuters, Investing.com ([investor.lilly.com](https://investor.lilly.com/news-releases/news-release-details/lilly-reports-third-quarter-2026-financial-results-raises-full))

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$LLY Insider Trading Activity

$LLY insiders have traded $LLY stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $LLY stock by insiders over the last 6 months:

PATRIK JONSSON (EVP & President, LLY Int'l) sold 6,500 shares for an estimated $7,638,149
ANAT HAKIM (EVP, GC & Secretary) sold 5,000 shares for an estimated $5,950,000
ILYA YUFFA (EVP&Pres, LLY USA&Global Capab) sold 2,500 shares for an estimated $2,876,925
DONALD A ZAKROWSKI (SVP, Finance, & CAO) sold 2,000 shares for an estimated $2,370,020

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$LLY Hedge Fund Activity

We have seen 2,506 institutional investors add shares of $LLY stock to their portfolio, and 1,671 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

JPMORGAN CHASE & CO added 12,598,524 shares (+inf%) to their portfolio in Q2 2026, for an estimated $15,111,047,641
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 6,001,955 shares (+inf%) to their portfolio in Q2 2026, for an estimated $7,198,924,885
CAPITAL RESEARCH GLOBAL INVESTORS removed 3,759,507 shares (-15.3%) from their portfolio in Q2 2026, for an estimated $4,509,265,481
WELLINGTON MANAGEMENT GROUP LLP removed 2,428,108 shares (-18.1%) from their portfolio in Q2 2026, for an estimated $2,912,345,578
FMR LLC added 2,121,444 shares (+8.1%) to their portfolio in Q2 2026, for an estimated $2,544,523,576
SG AMERICAS SECURITIES, LLC added 1,331,427 shares (+204.1%) to their portfolio in Q2 2026, for an estimated $1,596,953,486
GOLDMAN SACHS GROUP INC added 1,312,095 shares (+20.7%) to their portfolio in Q2 2026, for an estimated $1,573,766,105

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$LLY Congressional Stock Trading

Members of Congress have traded $LLY stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $LLY stock by members of Congress over the last 6 months:

REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 07/10.
REPRESENTATIVE MICHAEL A. RULLI sold up to $15,000 on 07/01.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $100,000 on 06/10.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$LLY Price Targets

Multiple analysts have issued price targets for $LLY recently. We have seen 11 analysts offer price targets for $LLY in the last 6 months, with a median target of $1350.0.

Here are some recent targets:

Trung Huynh from RBC Capital set a target price of $1500.0 on 07/08/2026
Robyn Karnauskas from Truist Securities set a target price of $1370.0 on 07/08/2026
Terence Flynn from Morgan Stanley set a target price of $1347.0 on 07/08/2026
Chris Schott from JP Morgan set a target price of $1400.0 on 07/07/2026
Carter Gould from Cantor Fitzgerald set a target price of $1350.0 on 07/06/2026
David Risinger from Leerink Partners set a target price of $1232.0 on 06/25/2026
Akash Tewari from Jefferies set a target price of $1350.0 on 06/09/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.